NCT06887205 Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study
| NCT ID | NCT06887205 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Lymphatic Reconstruction |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-06-10 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-06-10 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.
Eligibility Criteria
Inclusion Criteria: 1. Participants greater than or equal to 18 years of age. 2. Participants willing to participate. 3. Participants able to complete informed consent. 4. Participants with a diagnosis of Melanoma undergoing ALND or ILND. Exclusion Criteria: 1. Participant staking anticoagulants within 7 days prior to surgery. 2. Participants that are known to be pregnant at the time of surgery. 3. Participants with BMI greater than 50.0
Contact & Investigator
Ashleigh M Francis, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06887205 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lymphatic Reconstruction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06887205 currently recruiting?
Yes, NCT06887205 is actively recruiting participants. Contact the research team at amfrancis@mdanderson.org for enrollment information.
Where is the NCT06887205 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06887205 clinical trial?
NCT06887205 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Ashleigh M Francis, MD at M.D. Anderson Cancer Center. The trial plans to enroll 20 participants.